摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1α,25-dihydroxy-24-oxo-16-ene-20-cyclopropyl-vitamin D3 | 1143517-37-6

中文名称
——
中文别名
——
英文名称
1α,25-dihydroxy-24-oxo-16-ene-20-cyclopropyl-vitamin D3
英文别名
1alpha,25(OH)2-24-oxo-16-ene-20-cyclopropyl-vitamin D3;1-[1-[(3aS,4E,7aS)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-1-yl]cyclopropyl]-4-hydroxy-4-methylpentan-3-one
1α,25-dihydroxy-24-oxo-16-ene-20-cyclopropyl-vitamin D3化学式
CAS
1143517-37-6
化学式
C28H40O4
mdl
——
分子量
440.623
InChiKey
JKRFMOIIMQLASH-RFTHJHCXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    77.8
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    1α,3β-di(tert-butyl-dimethyl-silanyloxy)-25-trimethylsilanyloxy-16-ene-20-cyclopropyl-24-oxo-cholecalciferol 在 四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 40.0h, 以85%的产率得到1α,25-dihydroxy-24-oxo-16-ene-20-cyclopropyl-vitamin D3
    参考文献:
    名称:
    Synthesis and Anti-inflammatory Properties of 1α,25-Dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a Hypocalcemic, Stable Metabolite of 1α,25-Dihydroxy-16-ene-20-cyclopropyl-vitamin D3
    摘要:
    1 alpha,25(OH)(2)-16-ene-20-cyclopropyl-vitamin D-3 (13) is several fold more potent than the natural hormone 1 alpha,25-dihydroxyvitamin D-3 (1) as an anti-infilammatory agent. Here, we have further analyzed the anti-inflammatory properties of 13, confirming it as the most potent analogue tested within this family. We then determined the structures of all the natural metabolites of 13, including the 24-oxo metabolite 14, and carried out its synthesis. A comparison of 13 with 14 showed a similar induction of the primary VDR target genes CYP24A1 and CAMP and comparable anti-inflammatory properties as revealed by a similar inhibition of TNF-alpha, IL-12/23p40, IL-6, and IFN-gamma production. Interestingly, 14 displays a 3-fold lower calcemic activity in vivo compared to 13. Collectively, these findings indicate that the strong potency of 13 can be explained by the accumulation of its stable 24-oxo metabolite, which shows immunoregulatory and anti-inflammatory properties superimposable, to those exerted by 13 itself.
    DOI:
    10.1021/jm801365a
点击查看最新优质反应信息

文献信息

  • Synthesis and Anti-inflammatory Properties of 1α,25-Dihydroxy-16-ene-20-cyclopropyl-24-<i>oxo</i>-vitamin D<sub>3</sub>, a Hypocalcemic, Stable Metabolite of 1α,25-Dihydroxy-16-ene-20-cyclopropyl-vitamin D<sub>3</sub>
    作者:Gilles Laverny、Giuseppe Penna、Milan Uskokovic、Stanislaw Marczak、Hubert Maehr、Pawel Jankowski、Caroline Ceailles、Paul Vouros、Brenden Smith、Matthew Robinson、G. Satyanarayana Reddy、Luciano Adorini
    DOI:10.1021/jm801365a
    日期:2009.4.23
    1 alpha,25(OH)(2)-16-ene-20-cyclopropyl-vitamin D-3 (13) is several fold more potent than the natural hormone 1 alpha,25-dihydroxyvitamin D-3 (1) as an anti-infilammatory agent. Here, we have further analyzed the anti-inflammatory properties of 13, confirming it as the most potent analogue tested within this family. We then determined the structures of all the natural metabolites of 13, including the 24-oxo metabolite 14, and carried out its synthesis. A comparison of 13 with 14 showed a similar induction of the primary VDR target genes CYP24A1 and CAMP and comparable anti-inflammatory properties as revealed by a similar inhibition of TNF-alpha, IL-12/23p40, IL-6, and IFN-gamma production. Interestingly, 14 displays a 3-fold lower calcemic activity in vivo compared to 13. Collectively, these findings indicate that the strong potency of 13 can be explained by the accumulation of its stable 24-oxo metabolite, which shows immunoregulatory and anti-inflammatory properties superimposable, to those exerted by 13 itself.
查看更多